The ubiquitin-proteasome system and cancer

Essays in Biochemistry

Volumn 41, Issue , 2005, Pages 187-203

  Devoy, Anny ^a   Soane, Tim ^a   Welchman, Rebecca ^a   Mayer, R John ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Department of Molecular Cell Biology ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27144510147     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/eb0410187     Document Type: Review

References (26)

1. Mayer, R.J. (2005) The Nobel Prize for Chemistry 2004. Eur. Biopharm. Rev., Summer, 34-39
2. Simpson, M.V. (1953) The release of labeled amino acids from proteins in liver slices. J. Biol. Chem. 201, 143-154
3. Glickman, M.H. & Ciechanover, A. (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373-428
4. Evans, T., Rosenthal, E.T., Youngblom, J., Distel, D. & Hunt, T. (1983) Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33, 389-396
5. Cardozo, T. & Pagano, M. (2004) The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 5, 739-751
6. Reed, S.I. (2003) Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat. Rev. Mol. Cell Biol. 4, 855-864
7. Rape, M. & Kirschner, M.W. (2004) Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry. Nature (London) 432, 588-595
8. Brazil, P., Yang, Z.-Z. & Hemmings, B.A. (2004) Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29, 233-242
9. Sherr, C.J. & McCormack, F. (2002) The RB and p53 pathways in cancer. Cancer Cell 2, 103-112
10. Gill, G. (2004) SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18, 2046-2059
11. Kubbutat, M.H., Jones, S.N. & Vousden, K.H. (1997) Regulation of p53 stability by Mdm2. Nature (London) 387, 299-303
12. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K. & Cobb, M.H. (2001) Mitogen activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153-183
13. Hicke, L. (2001) Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol. 2, 195-201
14. Joazeiro, C.A., Wing, S.S., Huang, H., Leverson, J.D., Hunter, T. & Liu, Y.C. (1999) The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286, 309-312
15. Brummelkamp, T.R., Nijman, S.M., Dirac, A.M. & Bernards, R. (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature (London) 424, 797-801
16. Lu, Z., Xu, S., Joazeiro, C., Cobb, M.H. & Hunter, T. (2002) The PHD domain of MEKKI acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol. Cell 9, 945-956
17. Wertz, I.E., O'Rourke, K.M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S.D.L., Wu, P., Wiesmann, C., Baker, R., Boone, D.L. et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature (London) 430, 694-699
18. Pagano, M. & Benmaamar, R. (2003) When protein destruction runs amok, malignancy is on the loose. Cancer Cell 4, 251-256
19. Corn, P.G., McDonald, III, E.R., Herman, J.G. & El-Deiry, W.S. (2003) Tat-binding protein-1, a component of the 26 S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein. Nat. Genet. 35, 229-237
20. Gstaiger, M., Jordan, R., Lim, M., Catzavelos, C., Mestan, J., Slingerland, J. & Krek, W. (2001) Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. U.S.A. 98, 5043-5048
21. Dawson, S., Mee, M., Apcher, S., Higashitsuji, H., Baker, R., Uhle, S., Dubiel, W., Fujita, J. & Mayer, R.J. (2002) Gankyrin: an ankyrin-repeat oncoprotein interacts with Cdk4 kinase and the S6 ATPase of the 26 S proteasome. J. Biol. Chem. 277, 10893-10902
22. Higashitsuji, H., Itoh, K., Nagao, T., Dawson, S., Nonoguchi, K., Kido, T., Mayer, R.J., Arii, S. & Fujita, J. (2000) Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat. Med. 6, 96-99
23. Higashitsuji, H., Higashitsuji, H., Nagao, T., Itoh, K., Dawson, S., Mayer, R.J. & Fujita, J. (2003) Gankyrin, an oncoprotein commonly overexpressed in hepatocellular carcinomas, is anti-apoptotic and accelerates degradation of the tumor suppressor p53. Cancer Cell 8, 75-87
24. Hartmann-Petersen, R., Seeger, M. & Gordon, C. (2003) Transferring substrates to the 26 S proteasome. Trends Biochem. Sci. 28, 26-31
25. Goy, A. & Gilles, F. (2004) Update on the proteasome inhibitor bortezomib in hematologic malignancies. Clin. Lymphoma 4, 230-237
26. Vassilev, L.T., Vu, B.T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C. et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of Mdm2. Science 303, 844-848